Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03502239Not ApplicableCompleted

Cognitive Rehabilitation (Mega Team) and Its Effects on Emotional and Behavioral Regulation in ADHD, ASD, and CHD

Role: collaborator

NCT03835689Not ApplicableCompleted

Strongest FamiliesTM Neurodevelopmental

Role: collaborator

NCT04619862Phase 2Recruiting

Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial)

Role: collaborator

NCT04385927Not ApplicableCompleted

Life Beyond Trauma: 1-on-1 e-Health Program for Parents of Neurodiverse Children

Role: collaborator

All 4 trials loaded